Working… Menu

Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) (HEP001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01765283
Recruitment Status : Completed
First Posted : January 10, 2013
Last Update Posted : May 19, 2015
Information provided by (Responsible Party):
Promethera Biosciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2014
Actual Study Completion Date : April 2015